Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Arranz

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 26, 2019
Immune-related adverse events predict the therapeutic efficacy of anti-PD-1 antibodies in cancer patientsJ Rogado, J M Sánchez-Torres, N Romero-Laorden, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experienceJ Rodríguez, M D Caballero, A Gutiérrez, et al.
Bone Marrow Transplantation|April 21, 2001
Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimensA Salar, J Sierra, M Gandarillas, et al.
Transplantation Proceedings|March 20, 2003
Phase I/II trials of autologous peripheral blood stem cell transplantation in autoimmune diseases resistant to conventional therapy: preliminary results from the Spanish experienceI Espigado, A Marín-Niebla, M Rovira, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2013
Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantationC Martínez, C Canals, B Sarina, et al.
Bone Marrow Transplantation|January 9, 2021
Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow TransplantationE Domingo-Domenech, R F Duarte, A Boumedil, et al.
Annals of Hematology|May 1, 2014
Bendamustine as salvage treatment for patients with relapsed or refractory mantle cell lymphoma patients: a retrospective study of the Spanish experienceA García-Noblejas, C Martínez Chamorro, B Navarro Matilla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2004
Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experienceJ Rodriguez, M D Caballero, A Gutierrez, et al.
Annals of Hematology|May 25, 2017
Autologous stem cell transplantation (ASCT) in patients with mantle cell lymphoma: a retrospective study of the Spanish lymphoma group (GELTAMO)A García-Noblejas, J Cannata-Ortiz, E Conde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcomeM Constans, A Sureda, M J Terol, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|January 26, 2019
Immune-related adverse events predict the therapeutic efficacy of anti-PD-1 antibodies in cancer patientsJ Rogado, J M Sánchez-Torres, N Romero-Laorden, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experienceJ Rodríguez, M D Caballero, A Gutiérrez, et al.
Bone Marrow Transplantation|April 21, 2001
Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimensA Salar, J Sierra, M Gandarillas, et al.
Transplantation Proceedings|March 20, 2003
Phase I/II trials of autologous peripheral blood stem cell transplantation in autoimmune diseases resistant to conventional therapy: preliminary results from the Spanish experienceI Espigado, A Marín-Niebla, M Rovira, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 2013
Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantationC Martínez, C Canals, B Sarina, et al.
Bone Marrow Transplantation|January 9, 2021
Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow TransplantationE Domingo-Domenech, R F Duarte, A Boumedil, et al.
Annals of Hematology|May 1, 2014
Bendamustine as salvage treatment for patients with relapsed or refractory mantle cell lymphoma patients: a retrospective study of the Spanish experienceA García-Noblejas, C Martínez Chamorro, B Navarro Matilla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2004
Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experienceJ Rodriguez, M D Caballero, A Gutierrez, et al.
Annals of Hematology|May 25, 2017
Autologous stem cell transplantation (ASCT) in patients with mantle cell lymphoma: a retrospective study of the Spanish lymphoma group (GELTAMO)A García-Noblejas, J Cannata-Ortiz, E Conde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcomeM Constans, A Sureda, M J Terol, et al.
Pageof 8